About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Restructures

October 12, 2015

Click here to read more

Post navigation

Phosphagenics Begins its Animal Health and Nutrition Program

Phosphagenics Signs Development Agreement with tesa Labtec for TPM/Oxymorphone Patch

Related Posts

Receipt of R&D Tax Incentive

March 1, 2017

Oxymorphone Patch Program Update

May 14, 2015

Phosphagenics Announces Results of Dairy Trial

December 22, 2017

Recent Posts

Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
Dosing commences for Phase I human clinical trial
October 4, 2021
Biotech Webinar
September 23, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.